| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.52 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |